{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:28:35Z","timestamp":1790677715825,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11011-020-00619-x","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T09:02:43Z","timestamp":1600851763000},"page":"169-183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates"],"prefix":"10.1007","volume":"36","author":[{"given":"Rana Fadhil","family":"Mousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein Kadhem","family":"Al-Hakeim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Alhaideri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-871X","authenticated-orcid":false,"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"619_CR1","doi-asserted-by":"publisher","unstructured":"Al-Dujaili AH, Mousa RF, Al-Hakeim HK, Maes M (2019) High mobility group protein 1 and Dickkopf-related protein 1 in schizophrenia and treatment-resistant schizophrenia: associations with Interleukin-6, symptom domains, and neurocognitive impairments preprints 2019120100. https:\/\/doi.org\/10.20944\/preprints201912.0100.v1","DOI":"10.20944\/preprints201912.0100.v1"},{"key":"619_CR2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12640-019-00112-z","volume":"37","author":"HK Al-Hakeim","year":"2020","unstructured":"Al-Hakeim HK, Almulla AF, Maes M (2020) The Neuroimmune and neurotoxic fingerprint of major neurocognitive psychosis or deficit schizophrenia: a supervised machine learning study. Neurotox Res 37:753\u2013771","journal-title":"Neurotox Res"},{"key":"619_CR3","doi-asserted-by":"publisher","unstructured":"Almulla AF, Al-Hakeim HK, Abed MS, Carvalho AF, Maes M (2020a) Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways. Schizophr Res https:\/\/doi.org\/10.1016\/j.schres.2020.05.003","DOI":"10.1016\/j.schres.2020.05.003"},{"key":"619_CR4","doi-asserted-by":"publisher","unstructured":"Almulla AF, Al-Hakeim HK, Maes M (2020b) Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia CNS Spectr:1-10. https:\/\/doi.org\/10.1017\/s1092852920001182","DOI":"10.1017\/s1092852920001182"},{"key":"619_CR5","doi-asserted-by":"publisher","unstructured":"Andr\u00e9s-Rodr\u00edguez L et al. (2019) Peripheral immune aberrations in fibromyalgia: a systematic review, meta-analysis and meta-regression. Brain, behavior, and immunity. https:\/\/doi.org\/10.1016\/j.bbi.2019.12.020","DOI":"10.1016\/j.bbi.2019.12.020"},{"key":"619_CR6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.neurobiolaging.2005.03.010","volume":"27","author":"RM Barrientos","year":"2006","unstructured":"Barrientos RM, Higgins EA, Biedenkapp JC, Sprunger DB, Wright-Hardesty KJ, Watkins LR, Rudy JW, Maier SF (2006) Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol Aging 27:723\u2013732","journal-title":"Neurobiol Aging"},{"key":"619_CR7","doi-asserted-by":"crossref","unstructured":"Chae W-J, Bothwell AL (2019) Dickkopf1: an immunomodulatory ligand and Wnt antagonist in pathological inflammation differentiation","DOI":"10.1016\/j.diff.2019.05.003"},{"key":"619_CR8","first-page":"2167","volume":"6","author":"J Chen","year":"2017","unstructured":"Chen J (2017) Comorbidity investigations of gastrointestinal disorders with mental disorders in patients or animals. J Depress Anxiety 6:2167\u20131044.1000256","journal-title":"J Depress Anxiety"},{"key":"619_CR9","doi-asserted-by":"crossref","unstructured":"Chen Y-B, Huang F-S, Fen B, Yin J-B, Wang W, Li Y-Q (2015) Inhibitory effects of endomorphin-2 on excitatory synaptic transmission and the neuronal excitability of sacral parasympathetic preganglionic neurons in young rats Frontiers in cellular neuroscience 9:206","DOI":"10.3389\/fncel.2015.00206"},{"key":"619_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1742-2094-11-98","volume":"11","author":"JD Cherry","year":"2014","unstructured":"Cherry JD, Olschowka JA, O'Banion MK (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11:98. https:\/\/doi.org\/10.1186\/1742-2094-11-98","journal-title":"J Neuroinflammation"},{"key":"619_CR11","first-page":"229","volume":"125","author":"E Chesnokova","year":"2013","unstructured":"Chesnokova E, Dubynin V, Sarucheva N, Kalikhevich V, Ardemasova Z, Kamensky A (2013) Opioid peptides endomorphin-2 and soymorphin-5-amide are able to cross blood-brain barrier after intraperitoneal administration. J Neurochem 125:229","journal-title":"J Neurochem"},{"key":"619_CR12","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.biopsych.2019.05.012","volume":"86","author":"SD Clark","year":"2019","unstructured":"Clark SD, Abi-Dargham A (2019) The role of dynorphin and the kappa opioid receptor in the symptomatology of schizophrenia: A review of the evidence. Biol Psychiatry 86:502\u2013511","journal-title":"Biol Psychiatry"},{"key":"619_CR13","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1017\/S0033291709992054","volume":"40","author":"S Cockshell","year":"2010","unstructured":"Cockshell S, Mathias J (2010) Cognitive functioning in chronic fatigue syndrome: A meta-analysis. Psychol Med 40:1253\u20131267. https:\/\/doi.org\/10.1017\/S0033291709992054","journal-title":"Psychol Med"},{"key":"619_CR14","first-page":"729","volume":"16","author":"F Conti","year":"1998","unstructured":"Conti F, Pittoni V, Sacerdote P, Priori R, Meroni P, Valesini G (1998) Decreased immunoreactive beta-endorphin in mononuclear leucocytes from patients with chronic fatigue syndrome. Clin Exp Rheumatol 16:729\u2013732","journal-title":"Clin Exp Rheumatol"},{"key":"619_CR15","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1093\/brain\/awm173","volume":"130","author":"PR Corlett","year":"2007","unstructured":"Corlett PR et al (2007) Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions. Brain 130:2387\u20132400. https:\/\/doi.org\/10.1093\/brain\/awm173","journal-title":"Brain"},{"key":"619_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1017\/s1355617704101124","volume":"10","author":"J Deluca","year":"2004","unstructured":"Deluca J, Christodoulou C, Diamond BJ, Rosenstein ED, Kramer N, Natelson BH (2004) Working memory deficits in chronic fatigue syndrome: differentiating between speed and accuracy of information processing. Journal of the International Neuropsychological Society : JINS 10:101\u2013109. https:\/\/doi.org\/10.1017\/s1355617704101124","journal-title":"Journal of the International Neuropsychological Society : JINS"},{"key":"619_CR17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1017\/S1355617701733024","volume":"7","author":"BM Dobbs","year":"2001","unstructured":"Dobbs BM, Dobbs AR, Kiss I (2001) Working memory deficits associated with chronic fatigue syndrome. J Int Neuropsychol Soc 7:285\u2013293","journal-title":"J Int Neuropsychol Soc"},{"key":"619_CR18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/jpet.114.213074","volume":"349","author":"MA Erickson","year":"2014","unstructured":"Erickson MA, Morofuji Y, Owen JB, Banks WA (2014) Rapid transport of CCL11 across the blood-brain barrier: regional variation and importance of blood cells. J Pharmacol Exp Ther 349:497\u2013507","journal-title":"J Pharmacol Exp Ther"},{"key":"619_CR19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12974-016-0670-z","volume":"13","author":"BW Festoff","year":"2016","unstructured":"Festoff BW, Sajja RK, van Dreden P, Cucullo L (2016) HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer\u2019s disease. J Neuroinflammation 13:194","journal-title":"J Neuroinflammation"},{"key":"619_CR20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nrn1607","volume":"6","author":"PW Frankland","year":"2005","unstructured":"Frankland PW, Bontempi B (2005) The organization of recent and remote memories. Nat Rev Neurosci 6:119\u2013130","journal-title":"Nat Rev Neurosci"},{"key":"619_CR21","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1176\/ajp.2006.163.11.1918","volume":"163","author":"PD Harvey","year":"2006","unstructured":"Harvey PD, Patterson TL, Potter LS, Zhong K, Brecher M (2006) Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning. Am J Psychiatry 163:1918\u20131925. https:\/\/doi.org\/10.1176\/ajp.2006.163.11.1918","journal-title":"Am J Psychiatry"},{"key":"619_CR22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10597-014-9746-3","volume":"51","author":"L Hedlund","year":"2015","unstructured":"Hedlund L, Gyllensten AL, Hansson L (2015) A psychometric study of the multidimensional fatigue inventory to assess fatigue in patients with schizophrenia spectrum disorders. Community Ment Health J 51:377\u2013382","journal-title":"Community Ment Health J"},{"key":"619_CR23","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1523\/JNEUROSCI.4060-10.2011","volume":"31","author":"B Heinke","year":"2011","unstructured":"Heinke B, Gingl E, Sandk\u00fchler J (2011) Multiple targets of \u03bc-opioid receptor-mediated presynaptic inhibition at primary afferent A\u03b4-and C-fibers. J Neurosci 31:1313\u20131322","journal-title":"J Neurosci"},{"key":"619_CR24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3371\/CSRP.HUMI.070516","volume":"12","author":"ZD Hudson","year":"2018","unstructured":"Hudson ZD, Miller BJ (2018) Meta-analysis of cytokine and chemokine genes in schizophrenia. Clinical schizophrenia & related psychoses 12:121\u2013129B","journal-title":"Clinical schizophrenia & related psychoses"},{"key":"619_CR25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1101\/lm.32600","volume":"7","author":"JL Jankowsky","year":"2000","unstructured":"Jankowsky JL, Derrick BE, Patterson PH (2000) Cytokine responses to LTP induction in the rat hippocampus: a comparison of in vitro and in vivo techniques. Learn Mem 7:400\u2013412","journal-title":"Learn Mem"},{"key":"619_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s001270200013","volume":"37","author":"LA Jason","year":"2002","unstructured":"Jason LA et al (2002) A factor analysis of chronic fatigue symptoms in a community-based sample. Soc Psychiatry Psychiatr Epidemiol 37:183\u2013189. https:\/\/doi.org\/10.1007\/s001270200013","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"619_CR27","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s11011-017-9982-7","volume":"32","author":"B Kanchanatawan","year":"2017","unstructured":"Kanchanatawan B, Sirivichayakul S, Thika S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Noto C, Ivanova R, Maes M (2017) Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway. Metab Brain Dis 32:1003\u20131016","journal-title":"Metab Brain Dis"},{"key":"619_CR28","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1007\/s12035-017-0751-8","volume":"55","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B et al (2018a) Changes in tryptophan catabolite (TRYCAT) pathway patterning are associated with mild impairments in declarative memory in schizophrenia and deficits in semantic and episodic memory coupled with increased false-memory creation in deficit schizophrenia. Mol Neurobiol 55:5184\u20135201","journal-title":"Mol Neurobiol"},{"key":"619_CR29","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1007\/s12035-017-0465-y","volume":"55","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Maes M (2018b) Deficit schizophrenia is characterized by defects in IgM-mediated responses to tryptophan catabolites (TRYCATs): a paradigm shift towards defects in natural self-regulatory immune responses coupled with mucosa-derived TRYCAT pathway activation. Mol Neurobiol 55:2214\u20132226","journal-title":"Mol Neurobiol"},{"key":"619_CR30","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s12035-017-0417-6","volume":"55","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B et al (2018c) Deficit, but not nondeficit, schizophrenia is characterized by mucosa-associated activation of the tryptophan catabolite (TRYCAT) pathway with highly specific increases in IgA responses directed to picolinic, xanthurenic, and quinolinic acid. Mol Neurobiol 55:1524\u20131536","journal-title":"Mol Neurobiol"},{"key":"619_CR31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/jep.12945","volume":"24","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B et al (2018d) Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: results of unsupervised machine learning analysis. J Eval Clin Pract 24:879\u2013891","journal-title":"J Eval Clin Pract"},{"key":"619_CR32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12640-018-9868-4","volume":"33","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Thika S, Sirivichayakul S, Carvalho AF, Geffard M, Maes M (2018e) In schizophrenia, depression, anxiety, and physiosomatic symptoms are strongly related to psychotic symptoms and excitation, impairments in episodic memory, and increased production of neurotoxic tryptophan catabolites: a multivariate and machine learning study. Neurotox Res 33:641\u2013655","journal-title":"Neurotox Res"},{"key":"619_CR33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11011-018-0339-7","volume":"34","author":"B Kanchanatawan","year":"2019","unstructured":"Kanchanatawan B, Sriswasdi S, Maes M (2019) Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia. Metab Brain Dis 34:267\u2013282","journal-title":"Metab Brain Dis"},{"key":"619_CR34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"619_CR35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","volume":"68","author":"RS Keefe","year":"2004","unstructured":"Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L (2004) The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 68:283\u2013297","journal-title":"Schizophr Res"},{"key":"619_CR36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000369972","volume":"7","author":"MS Kwak","year":"2015","unstructured":"Kwak MS et al (2015) HMGB1 binds to Lipoteichoic acid and enhances TNF-a and IL-6 production through HMGB1-mediated transfer of Lipoteichoic acid to CD14 and TLR2. Journal of Innate Immunity 7:405\u2013416","journal-title":"Journal of Innate Immunity"},{"key":"619_CR37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","volume":"28","author":"BB Land","year":"2008","unstructured":"Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C (2008) The dysphoric component of stress is encoded by activation of the dynorphin \u03ba-opioid system. J Neurosci 28:407\u2013414","journal-title":"J Neurosci"},{"key":"619_CR38","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.neuroimage.2005.02.011","volume":"26","author":"G Lange","year":"2005","unstructured":"Lange G et al (2005) Objective evidence of cognitive complaints in chronic fatigue syndrome: a BOLD fMRI study of verbal working memory. NeuroImage 26:513\u2013524. https:\/\/doi.org\/10.1016\/j.neuroimage.2005.02.011","journal-title":"NeuroImage"},{"key":"619_CR39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.comppsych.2019.01.003","volume":"90","author":"Y Luo","year":"2019","unstructured":"Luo Y, He H, Zhang J, Ou Y, Fan N (2019) Changes in serum TNF-\u03b1, IL-18, and IL-6 concentrations in patients with chronic schizophrenia at admission and at discharge. Compr Psychiatry 90:82\u201387","journal-title":"Compr Psychiatry"},{"key":"619_CR40","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1046\/j.1471-4159.2003.02157.x","volume":"88","author":"AM Lynch","year":"2004","unstructured":"Lynch AM, Walsh C, Delaney A, Nolan Y, Campbell VA, Lynch MA (2004) Lipopolysaccharide-induced increase in signalling in hippocampus is abrogated by IL-10--a role for IL-1 beta? J Neurochem 88:635\u2013646. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.02157.x","journal-title":"J Neurochem"},{"key":"619_CR41","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.pnpbp.2010.06.023","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M (2011) An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. Prog Neuro-Psychopharmacol Biol Psychiatry 35:784\u2013794. https:\/\/doi.org\/10.1016\/j.pnpbp.2010.06.023","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"619_CR42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1741-7015-8-35","volume":"8","author":"M Maes","year":"2010","unstructured":"Maes M, Twisk FN (2010) Chronic fatigue syndrome: Harvey and Wessely's (bio) psychosocial model versus a bio (psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. BMC Med 8:35","journal-title":"BMC Med"},{"key":"619_CR43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jad.2006.08.021","volume":"99","author":"M Maes","year":"2007","unstructured":"Maes M, Mihaylova I, Leunis J-C (2007) Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut\u2013intestinal permeability. J Affect Disord 99:237\u2013240","journal-title":"J Affect Disord"},{"key":"619_CR44","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.psychres.2012.03.031","volume":"200","author":"M Maes","year":"2012","unstructured":"Maes M, Twisk FN, Johnson C (2012a) Myalgic encephalomyelitis (ME), chronic fatigue syndrome (CFS), and chronic fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data. Psychiatry Res 200:754\u2013760. https:\/\/doi.org\/10.1016\/j.psychres.2012.03.031","journal-title":"Psychiatry Res"},{"key":"619_CR45","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000336803","volume":"81","author":"M Maes","year":"2012","unstructured":"Maes M, Twisk FN, Ringel K (2012b) Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis\/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis\/chronic fatigue syndrome than in depression. Psychother Psychosom 81:286\u2013295","journal-title":"Psychother Psychosom"},{"key":"619_CR46","doi-asserted-by":"publisher","unstructured":"Maes M, Ringel K, Kubera M, Anderson G, Morris G, Galecki P, Geffard M (2013) In myalgic encephalomyelitis\/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation journal of affective disorders 150:223-230. https:\/\/doi.org\/10.1016\/j.jad.2013.03.029","DOI":"10.1016\/j.jad.2013.03.029"},{"key":"619_CR47","first-page":"439","volume":"36","author":"M Maes","year":"2015","unstructured":"Maes M, Bosmans E, Kubera M (2015) Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic encephalomyelitis\/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+\/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers. Neuro endocrinology letters 36:439\u2013446","journal-title":"Neuro endocrinology letters"},{"key":"619_CR48","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12640-019-00054-6","volume":"36","author":"M Maes","year":"2019","unstructured":"Maes M, Sirivichayakul S, Kanchanatawan B, Vodjani A (2019) Breakdown of the paracellular tight and adherens junctions in the gut and blood brain barrier and damage to the vascular barrier in patients with deficit schizophrenia. Neurotox Res 36:306\u2013322","journal-title":"Neurotox Res"},{"key":"619_CR49","doi-asserted-by":"crossref","unstructured":"Maes M et al. (2020) Increased levels of plasma tumor necrosis factor-\u03b1 mediate schizophrenia symptom dimensions and neurocognitive impairments and are inversely associated with natural IgM directed to malondialdehyde and paraoxonase 1 activity molecular. Neurobiology:1\u201313","DOI":"10.1007\/s12035-020-01882-w"},{"key":"619_CR50","doi-asserted-by":"crossref","first-page":"E7150","DOI":"10.1073\/pnas.1710519114","volume":"114","author":"JG Montoya","year":"2017","unstructured":"Montoya JG et al (2017) Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci 114:E7150\u2013E7158","journal-title":"Proc Natl Acad Sci"},{"key":"619_CR51","first-page":"185","volume":"34","author":"G Morris","year":"2013","unstructured":"Morris G, Maes M (2013) Case definitions and diagnostic criteria for Myalgic Encephalomyelitis and Chronic fatigue Syndrome: from clinical-consensus to evidence-based case definitions. Neuro endocrinology letters 34:185\u2013199","journal-title":"Neuro endocrinology letters"},{"key":"619_CR52","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s12035-015-9090-9","volume":"53","author":"G Morris","year":"2016","unstructured":"Morris G, Berk M, Galecki P, Walder K, Maes M (2016a) The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases. Mol Neurobiol 53:1195\u20131219","journal-title":"Mol Neurobiol"},{"key":"619_CR53","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/1381612822666151215102420","volume":"22","author":"GF Morris","year":"2016","unstructured":"Morris GF, Carvalho A, Anderson G, Galecki P, Maes M (2016b) The many neuroprogressive actions of tryptophan catabolites (TRYCATs) that may be associated with the pathophysiology of neuro-immune disorders. Curr Pharm Des 22:963\u2013977","journal-title":"Curr Pharm Des"},{"key":"619_CR54","doi-asserted-by":"publisher","unstructured":"Moustafa SR, Al-Rawi KF, Stoyanov D, Al-Dujaili AH, Supasitthumrong T, Al-Hakeim HK, Maes M (2020) The endogenous opioid system in schizophrenia and treatment resistant schizophrenia: increased plasma Endomorphin 2, and \u03ba and \u03bc opioid receptors are associated with Interleukin-6 diagnostics (Basel) 10. https:\/\/doi.org\/10.3390\/diagnostics10090633","DOI":"10.3390\/diagnostics10090633"},{"key":"619_CR55","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/10550490902925862","volume":"18","author":"D Mysels","year":"2009","unstructured":"Mysels D (2009) The kappa-opiate receptor impacts the pathophysiology and behavior of substance use. Am J Addict 18:272\u2013276","journal-title":"Am J Addict"},{"key":"619_CR56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-010-1834-7","volume":"210","author":"CL Nemeth","year":"2010","unstructured":"Nemeth CL, Paine TA, Rittiner JE, B\u00e9guin C, Carroll FI, Roth BL, Cohen BM, Carlezon WA Jr (2010) Role of kappa-opioid receptors in the effects of salvinorin a and ketamine on attention in rats. Psychopharmacology 210:263\u2013274","journal-title":"Psychopharmacology"},{"key":"619_CR57","doi-asserted-by":"publisher","first-page":"9354","DOI":"10.1074\/jbc.M412170200","volume":"280","author":"Y Nolan","year":"2005","unstructured":"Nolan Y, Maher FO, Martin DS, Clarke RM, Brady MT, Bolton AE, Mills KHG, Lynch MA (2005) Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus. J Biol Chem 280:9354\u20139362. https:\/\/doi.org\/10.1074\/jbc.M412170200","journal-title":"J Biol Chem"},{"key":"619_CR58","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/jnc.12492","volume":"128","author":"JA Orellana","year":"2014","unstructured":"Orellana JA, S\u00e1ez JC, Bennett MVL, Berman JW, Morgello S, Eugenin EA (2014) HIV increases the release of dickkopf-1 protein from human astrocytes by a Cx43 hemichannel-dependent mechanism. J Neurochem 128:752\u2013763","journal-title":"J Neurochem"},{"key":"619_CR59","first-page":"97","volume":"24","author":"JE Overall","year":"1988","unstructured":"Overall JE, Gorham DR (1988) The brief psychiatric rating scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull 24:97\u201399","journal-title":"Psychopharmacol Bull"},{"key":"619_CR60","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.schres.2011.07.030","volume":"133","author":"LB Palmese","year":"2011","unstructured":"Palmese LB, DeGeorge PC, Ratliff JC, Srihari VH, Wexler BE, Krystal AD, Tek C (2011) Insomnia is frequent in schizophrenia and associated with night eating and obesity. Schizophr Res 133:238\u2013243","journal-title":"Schizophr Res"},{"key":"619_CR61","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00002508-200207000-00008","volume":"18","author":"AE Panerai","year":"2002","unstructured":"Panerai AE et al (2002) Peripheral blood mononuclear cell \u03b2-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report. Clin J Pain 18:270\u2013273","journal-title":"Clin J Pain"},{"key":"619_CR62","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.cell.2013.11.030","volume":"155","author":"CN Parkhurst","year":"2013","unstructured":"Parkhurst CN et al (2013) Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155:1596\u20131609. https:\/\/doi.org\/10.1016\/j.cell.2013.11.030","journal-title":"Cell"},{"key":"619_CR63","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-3083.1989.tb01138.x","volume":"29","author":"J Prieto","year":"1989","unstructured":"Prieto J, Subira M, Castilla A, Arroyo J, Serrano M (1989) Opioid peptides modulate the organization of vimentin filaments, phagocytic activity, and expression of surface molecules in monocytes. Scand J Immunol 29:391\u2013398","journal-title":"Scand J Immunol"},{"key":"619_CR64","unstructured":"Ringle CM (2015) Ringle, Christian M., Wende, Sven, & Becker, Jan-Michael.(2015). SmartPLS 3. B\u00f6nningstedt: SmartPLS"},{"key":"619_CR65","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12967-017-1371-9","volume":"15","author":"ME Roerink","year":"2017","unstructured":"Roerink ME, Knoop H, Bronkhorst EM, Mouthaan HA, Hawinkels LJ, Joosten LA, van der Meer JW (2017) Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment. J Transl Med 15:267","journal-title":"J Transl Med"},{"key":"619_CR66","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s12035-019-01737-z","volume":"57","author":"C Roomruangwong","year":"2020","unstructured":"Roomruangwong C, Noto C, Kanchanatawan B, Anderson G, Kubera M, Carvalho AF, Maes M (2020) The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia. Mol Neurobiol 57:778\u2013797","journal-title":"Mol Neurobiol"},{"key":"619_CR67","first-page":"162","volume":"7","author":"PC Salinas","year":"2013","unstructured":"Salinas PC (2013) Wnts in action: from synapse formation to synaptic maintenance. Front Cell Neurosci 7:162","journal-title":"Front Cell Neurosci"},{"key":"619_CR68","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nbd.2006.06.016","volume":"24","author":"C Scali","year":"2006","unstructured":"Scali C et al (2006) Inhibition of Wnt signaling, modulation of tau phosphorylation and induction of neuronal cell death by DKK1. Neurobiol Dis 24:254\u2013265","journal-title":"Neurobiol Dis"},{"key":"619_CR69","doi-asserted-by":"crossref","first-page":"7778","DOI":"10.1073\/pnas.95.13.7778","volume":"95","author":"H Schneider","year":"1998","unstructured":"Schneider H, Pitossi F, Balschun D, Wagner A, Del Rey A, Besedovsky H (1998) A neuromodulatory role of interleukin-1\u03b2 in the hippocampus. Proc Natl Acad Sci 95:7778\u20137783","journal-title":"Proc Natl Acad Sci"},{"key":"619_CR70","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.biopsych.2019.08.004","volume":"86","author":"A Shekhar","year":"2019","unstructured":"Shekhar A (2019) Role of kappa opioid receptors in symptoms of schizophrenia: what is the neurobiology? Biol Psychiatry 86:494\u2013496","journal-title":"Biol Psychiatry"},{"key":"619_CR71","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12640-018-9937-8","volume":"35","author":"S Sirivichayakul","year":"2019","unstructured":"Sirivichayakul S, Kanchanatawan B, Thika S, Carvalho AF, Maes M (2019) Eotaxin, an endogenous cognitive deteriorating chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in schizophrenia patients. Neurotox Res 35:122\u2013138","journal-title":"Neurotox Res"},{"key":"619_CR72","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1176\/appi.ajp.157.9.1492","volume":"157","author":"P Skapinakis","year":"2000","unstructured":"Skapinakis P, Lewis G, Meltzer H (2000) Clarifying the relationship between unexplained chronic fatigue and psychiatric morbidity: results from a community survey in Great Britain. Am J Psychiatr 157:1492\u20131498","journal-title":"Am J Psychiatr"},{"key":"619_CR73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000448957","volume":"86","author":"A Slyepchenko","year":"2017","unstructured":"Slyepchenko A et al (2017) Gut microbiota, bacterial translocation, and interactions with diet: pathophysiological links between major depressive disorder and non-communicable medical comorbidities. Psychother Psychosom 86:31\u201346","journal-title":"Psychother Psychosom"},{"key":"619_CR74","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0306-9877(95)90062-4","volume":"45","author":"R Smith","year":"1995","unstructured":"Smith R, Maes M (1995) The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Med Hypotheses 45:135\u2013141","journal-title":"Med Hypotheses"},{"key":"619_CR75","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2174\/18715273113129990099","volume":"12","author":"J Steiner","year":"2013","unstructured":"Steiner J, Gos T, Bogerts B, Bielau H, Drexhage HA, Bernstein HG (2013) Possible impact of microglial cells and the monocyte-macrophage system on suicidal behavior CNS. Neurol Disord Drug Targets 12:971\u2013979. https:\/\/doi.org\/10.2174\/18715273113129990099","journal-title":"Neurol Disord Drug Targets"},{"key":"619_CR76","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1471-244X-12-193","volume":"12","author":"P \u015awitaj","year":"2012","unstructured":"\u015awitaj P, Anczewska M, Chrostek A, Sabariego C, Cieza A, Bickenbach J, Chatterji S (2012) Disability and schizophrenia: a systematic review of experienced psychosocial difficulties. BMC psychiatry 12:193","journal-title":"BMC psychiatry"},{"issue":"Suppl 3","key":"619_CR77","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1097\/00004850-199803003-00004","volume":"13","author":"CA Tamminga","year":"1998","unstructured":"Tamminga CA, Buchanan RW, Gold JM (1998) The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. Int Clin Psychopharmacol 13(Suppl 3):S21\u2013S26. https:\/\/doi.org\/10.1097\/00004850-199803003-00004","journal-title":"Int Clin Psychopharmacol"},{"key":"619_CR78","first-page":"250","volume-title":"Enhanced brain opioid receptor activity precedes blood-brain barrier disruption","author":"P Ting","year":"1997","unstructured":"Ting P, Cushenberry P, Friedman T, Loh Y (1997) Enhanced brain opioid receptor activity precedes blood-brain barrier disruption. Brain Edema X. Springer, In, pp 250\u2013253"},{"key":"619_CR79","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/mp.2016.90","volume":"21","author":"MO Tr\u00e9panier","year":"2016","unstructured":"Tr\u00e9panier MO, Hopperton KE, Mizrahi R, Mechawar N, Bazinet RP (2016) Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry 21:1009\u20131026. https:\/\/doi.org\/10.1038\/mp.2016.90","journal-title":"Mol Psychiatry"},{"key":"619_CR80","doi-asserted-by":"crossref","unstructured":"Waters F, Naik N, Rock D (2013) Sleep, fatigue, and functional health in psychotic patients Schizophrenia research and treatment 2013","DOI":"10.1155\/2013\/425826"},{"key":"619_CR81","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbi.2010.10.015","volume":"25","author":"R Yirmiya","year":"2011","unstructured":"Yirmiya R, Goshen I (2011) Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 25:181\u2013213. https:\/\/doi.org\/10.1016\/j.bbi.2010.10.015","journal-title":"Brain Behav Immun"},{"key":"619_CR82","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-3999(01)00315-4","volume":"52","author":"O Zachrisson","year":"2002","unstructured":"Zachrisson O, Regland B, Jahreskog M, Kron M, Gottfries CG (2002) A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). J Psychosom Res 52:501\u2013509","journal-title":"J Psychosom Res"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00619-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-020-00619-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00619-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T23:37:44Z","timestamp":1632353864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-020-00619-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1007\/s11011-020-00619-x","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"assertion":[{"value":"23 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest with any commercial or other association in connection with the submitted article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}